Keyword: Eli Lilly

News

Amgen to Buy Turkish Drugmaker for $700 mln

25.04.2012 - U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...

News

Piramal Sees $1.5 Billion Revenue from Potential Alzheimer's Drug

16.04.2012 - Indian drugmaker Piramal Healthcare sees revenue potential of $1.5 billion from its new florbetaben molecule, a possible Alzheimer's treatment acquired by the company in a deal...

News

Icahn Sues Amylin, Pushes for Sale

09.04.2012 - Carl Icahn sued Amylin Pharmaceuticals on Monday to extend a deadline for nominating directors, as the activist investor pushes to win enough board seats to engineer a sale of the...

News

Amylin Rejected $3.5 bln Bristol Offer

28.03.2012 - Shares of Amylin Pharmaceuticals rose as much as 51% on Wednesday after Bloomberg News reported the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers...

News

Hovione Announces Appointment of Colin Minchom as Vice President, Particle Design Business Unit

15.03.2012 - Hovione announced the appointment of Dr. Colin Minchom as Vice President of its Particle Design Business Unit. Dr. Minchom was most recently with Patheon where he held the position...

News

Colin Minchom Appointed VP Particle Design BU at Hovione

15.03.2012 - Hovione said it has appointed Dr. Colin Minchom as vice president of its Particle Design business unit. Dr. Minchom was most recently with Patheon where he held the position of...

News

Bayer Sounds Out Debt Market with Eye On Deals

12.03.2012 - Bayer is sounding out its debt financing options with banks to prepare for takeover opportunities such as one that may arise from Pfizer's mooted exit from veterinary medicine...

Sites & Services

Indiana’s Government Caters to Businesses

25.01.2012 - Bio-Logical - Indiana is developing a breakthrough that will change the future of life sciences. It's a new way of encapsulating the infrastructure, tax incentives, research...